Phase I/II trial of preoperative oxaliplatin, docetaxel, capecitabine, and radiation for localized esophageal cancer

A. A. Meluch,David R. Spigel,F. A. Greco,DA Yardley,H. A. Burris,C. Farley,J. D. Peyton,Dianna Shipley,Ronald G. Steis,John D. Hainsworth

Phase I/II trial of preoperative oxaliplatin, docetaxel, capecitabine, and radiation for localized esophageal cancer

2016

A. A. Meluch
David R. Spigel
F. A. Greco
DA Yardley
H. A. Burris
C. Farley
J. D. Peyton
Dianna Shipley
Ronald G. Steis
John D. Hainsworth

4595 Background: Preoperative chemoradiotherapy is a primary treatment option for patients (pts) with resectable esophageal cancer. Combination regimens using newer agents may improve pt outcomes. ...

Keywords:

Oxaliplatin
Oncology
Capecitabine
Chemoradiotherapy
Internal medicine
Medicine
Esophageal cancer
Pathology
Docetaxel
preoperative chemoradiotherapy
primary treatment
phase i ii

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations